Pioglitazone is sold as a single-ingredient product under the brand-name Actos and is also sold in combination with metformin (Actoplus Met, Actoplus Met XR) and glimepiride (Duetact). It is used along with diet and exercise to improve control of blood sugar in adults with type 2 diabetes mellitus.
Adverse reactions or quality problems experienced with the use of these products may be reported to the FDA’s MedWatch Adverse Event Reporting program using the contact information at the bottom of this page.
